Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances

Haematologica

Volumn 90, Issue 8, 2005, Pages 1110-1115

  Silva, Fernanda Azevedo ^a   Matos, Janini O ^a   Mello, Fernanda C De Q ^a   Nucci, Marcio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cancer; Mortality; Risk factor; Tuberculosis

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; ETHIONAMIDE; FLUDARABINE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; HAIRY CELL LEUKEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASIA; NONHODGKIN LYMPHOMA; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS;

EID: 24944544779     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-99.
2. Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant disease. Arch Intern Med 1976;136:67-70.
3. Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer 1974;33:850-8.
4. Karachunskii MA, Pivnik AV, Iuldasheva NE. Tuberculosis in patients with hemoblastoses. Probl Tuberk 2002;12:24-7.
5. Cliffton EE, Irani BB. Pulmonary tuberculosis and cancer. N Y State J Med 1970;70:274-8.
6. Coburn RJ, England JM, Samson DM, Walford DM, Blowers R, Chanarin I, et al. Tuberculosis and blood disorders. Br J Haematol 1973;25:793-9.
7. Karnak D, Kayacan O, Beder S. Reactivation of pulmonary tuberculosis in malignancy. Tumori 2002;88:251-4.
8. Lowther CP. Leukemia and tuberculosis. Ann Intern Med 1959;51:52-6.
9. Morrow LB, Anderson RE. Active tuberculosis in leukemia, malignant lymphoma and myelofibrosis. Arch Pathol 1965;79:484-93.
10. Srivastava VM, Krishnaswami H, Srivastava A, Dennison D, Chandy M. Infections in haematological malignancies: an autopsy study of 72 cases. Trans R Soc Trop Med Hyg 1996;90:406-8.
11. Tsiodras S, Samonis G, Keating MJ, Kontoyiannis DP. Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc 2000;75:1039-54.
12. Platsoucas CD, Galinski M, Kempin S, Reich L, Clarkson B, Good RA. Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. J Immunol 1982;129:2305-12.
13. Morrison VA. The infectious complications of chronic lymphocytic leukemia. Semin Oncol 1998;25:98-106.
14. Travade P, Dusart JD, Cavaroc M, Beytout J, Rey M. Severe infections associated with chronic lymphoid leukemia. 159 infectious episodes in 60 patients. Presse Med 1986;15:1715-8.
15. Anaissie EJ, Kontoyiannis DP, O'Brien S, Kantarjian H, Robertson L, Lerner S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998;129:559-66.
16. Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, et al. Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011. J Clin Oncol 2001;19:3611-21.
17. Abad S, Gyan E, Moachon L, Bouscary D, Sicard D, Dreyfus F, et al. Tuberculosis due to Mycobacterium bovis after alemtuzumab administration. Clin Infect Dis 2003;37:e27-e8.
18. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999;5:444-7.
19. Sanders C, Perez EA, Lawrence HJ. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine. Am J Hematol 1992;39:314-5.
20. Ghosh K, Sivakumaran M, Murphy P, Chapman CS. Pulmonary tuberculosis after fludarabine for chronic lymphocytic leukaemia. Natl Med J India 1995;8:294-5.
21. De La Rosa GR, Jacobson KL, Rolston KV, Raad II, Kontoyiannis DP, Safdar A. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000. Clin Microbiol Infect 2004;10:749-52.
22. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 2000;161:1376-95.
23. de la CR, Martino R, Granados E, Rodriguez-Salvanes FJ, Rovira M, Cabrera R, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000;26:291-8.
24. Hayward AC, Darton T, Van-Tam JN, Watson JM, Coker R, Schwoebel V. Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis 2004;7:751-7.